| Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression E Becht, NA Giraldo, L Lacroix, B Buttard, N Elarouci, F Petitprez, J Selves, ... Genome biology 17 (1), 1-20, 2016 | 1639 | 2016 |
| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1251 | 2020 |
| B cells are associated with survival and immunotherapy response in sarcoma F Petitprez, A de Reyniès, EZ Keung, TWW Chen, CM Sun, J Calderaro, ... Nature 577 (7791), 556-560, 2020 | 1019 | 2020 |
| Tertiary lymphoid structures in the era of cancer immunotherapy C Sautès-Fridman, F Petitprez, J Calderaro, WH Fridman Nature Reviews Cancer 19 (6), 307-325, 2019 | 755 | 2019 |
| Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology G Sturm, F Finotello, F Petitprez, JD Zhang, J Baumbach, WH Fridman, ... Bioinformatics 35 (14), i436-i445, 2019 | 467 | 2019 |
| The clinical role of the TME in solid cancer NA Giraldo, R Sanchez-Salas, JD Peske, Y Vano, E Becht, F Petitprez, ... British journal of cancer 120 (1), 45-53, 2019 | 331 | 2019 |
| The tumor microenvironment in the response to immune checkpoint blockade therapies F Petitprez, M Meylan, A de Reyniès, C Sautès-Fridman, WH Fridman Frontiers in immunology 11, 784, 2020 | 287 | 2020 |
| Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell CarcinomaT-cell Immunophenotype in Renal Cell Carcinoma NA Giraldo, E Becht, Y Vano, F Petitprez, L Lacroix, P Validire, ... Clinical Cancer Research 23 (15), 4416-4428, 2017 | 238 | 2017 |
| Context-dependent roles of complement in cancer LT Roumenina, MV Daugan, F Petitprez, C Sautès-Fridman, WH Fridman Nature Reviews Cancer 19 (12), 698-715, 2019 | 211 | 2019 |
| Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma J Calderaro, F Petitprez, E Becht, A Laurent, TZ Hirsch, B Rousseau, ... Journal of hepatology 70 (1), 58-65, 2019 | 182 | 2019 |
| Tumor cells hijack macrophage-produced complement C1q to promote tumor GrowthIntratumoral complement promotes cancer progression LT Roumenina, MV Daugan, R Noé, F Petitprez, YA Vano, ... Cancer immunology research 7 (7), 1091-1105, 2019 | 150 | 2019 |
| Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy S Chauvet, V Frémeaux-Bacchi, F Petitprez, A Karras, L Daniel, S Burtey, ... Blood, The Journal of the American Society of Hematology 129 (11), 1437-1447, 2017 | 135 | 2017 |
| Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer M Meylan, F Petitprez, E Becht, A Bougoüin, G Pupier, A Calvez, I Giglioli, ... Immunity 55 (3), 527-541. e5, 2022 | 112 | 2022 |
| PD-L1 expression and CD8+ T-cell infiltrate are associated with clinical progression in patients with node-positive prostate cancer F Petitprez, N Fossati, Y Vano, M Freschi, E Becht, R Luciano, J Calderaro, ... European urology focus 5 (2), 192-196, 2019 | 94 | 2019 |
| C5 nephritic factors drive the biological phenotype of C3 glomerulopathies MC Marinozzi, S Chauvet, M Le Quintrec, M Mignotet, F Petitprez, ... Kidney international 92 (5), 1232-1241, 2017 | 86 | 2017 |
| B cells and cancer: To B or not to B? WH Fridman, F Petitprez, M Meylan, TWW Chen, CM Sun, LT Roumenina, ... Journal of Experimental Medicine 218 (1), e20200851, 2020 | 83 | 2020 |
| Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies F Petitprez, YA Vano, E Becht, NA Giraldo, A De Reyniès, ... Cancer Immunology, Immunotherapy 67 (6), 981-988, 2018 | 83 | 2018 |
| B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome WH Fridman, M Meylan, F Petitprez, CM Sun, A Italiano, ... Nature Reviews Clinical Oncology 19 (7), 441-457, 2022 | 81 | 2022 |
| Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome J Zuber, M Frimat, S Caillard, N Kamar, P Gatault, F Petitprez, L Couzi, ... Journal of the American Society of Nephrology 30 (12), 2449-2463, 2019 | 80 | 2019 |
| Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer AM Weinstein, NA Giraldo, F Petitprez, C Julie, L Lacroix, F Peschaud, ... Cancer Immunology, Immunotherapy 68 (1), 109-120, 2019 | 68 | 2019 |
